Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects.
Goldner G, Zimmermann F, Feldmann H, Glocker S, Wachter-Gerstner N, Geinitz H, Becker G, Pötzi R, Wambersie A, Bamberg M, Molls M, Wachter S, Pötter R. Goldner G, et al. Among authors: wachter gerstner n. Radiother Oncol. 2006 Jan;78(1):36-40. doi: 10.1016/j.radonc.2005.10.009. Epub 2005 Nov 3. Radiother Oncol. 2006. PMID: 16271410
3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment.
Goldner G, Geinitz H, Wachter S, Becker G, Zimmermann F, Wachter-Gerstner N, Glocker S, Pötzi R, Wambersie A, Bamberg M, Molls M, Feldmann H, Pötter R. Goldner G, et al. Among authors: wachter gerstner n. Wien Klin Wochenschr. 2006 May;118(7-8):224-9. doi: 10.1007/s00508-006-0588-z. Wien Klin Wochenschr. 2006. PMID: 16794760 Clinical Trial.
Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients.
Goldner G, Tomicek B, Becker G, Geinitz H, Wachter S, Zimmermann F, Wachter-Gerstner N, Reibenwein J, Glocker S, Bamberg M, Feldmann H, Pötzi R, Molls M, Pötter R. Goldner G, et al. Among authors: wachter gerstner n. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):78-83. doi: 10.1016/j.ijrobp.2006.08.055. Int J Radiat Oncol Biol Phys. 2007. PMID: 17189064 Clinical Trial.
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial.
Goldner G, Bombosch V, Geinitz H, Becker G, Wachter S, Glocker S, Zimmermann F, Wachter-Gerstner N, Schrott A, Bamberg M, Molls M, Feldmann H, Pötter R. Goldner G, et al. Among authors: wachter gerstner n. Strahlenther Onkol. 2009 Feb;185(2):94-100. doi: 10.1007/s00066-009-1970-3. Epub 2009 Feb 25. Strahlenther Onkol. 2009. PMID: 19240995 Clinical Trial.
16 results